Panacea Life Sciences Holdings Inc
Panacea Life Sciences Holdings, Inc., operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals. It provides a range of products, including Nitro Kava, Kratom, hemp, VAPE products, and various beverages that focuses on promoting alternative health and… Read more
Market Cap & Net Worth: Panacea Life Sciences Holdings Inc (PLSH)
Panacea Life Sciences Holdings Inc (OTCQB:PLSH) has a market capitalization of $848.95K ($848.95K) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #37508 globally and #12213 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Panacea Life Sciences Holdings Inc's stock price $0.04 by its total outstanding shares 21223788 (21.22 Million).
Panacea Life Sciences Holdings Inc Market Cap History: 2021 to 2025
Panacea Life Sciences Holdings Inc's market capitalization history from 2021 to 2025. Data shows change from $15.28 Million to $848.95K (-63.36% CAGR).
Panacea Life Sciences Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Panacea Life Sciences Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.33x
Panacea Life Sciences Holdings Inc's market cap is 1.33 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $15.28 Million | $2.06 Million | -$4.78 Million | 7.42x | N/A |
| 2022 | $1.49 Million | $1.63 Million | -$9.14 Million | 0.92x | N/A |
| 2023 | $3.18 Million | $2.38 Million | -$8.02 Million | 1.33x | N/A |
Competitor Companies of PLSH by Market Capitalization
Companies near Panacea Life Sciences Holdings Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Panacea Life Sciences Holdings Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Panacea Life Sciences Holdings Inc Historical Marketcap From 2021 to 2025
Between 2021 and today, Panacea Life Sciences Holdings Inc's market cap moved from $15.28 Million to $ 848.95K, with a yearly change of -63.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $848.95K | -34.43% |
| 2024 | $1.29 Million | -59.33% |
| 2023 | $3.18 Million | +113.37% |
| 2022 | $1.49 Million | -90.24% |
| 2021 | $15.28 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Panacea Life Sciences Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $848.95K USD |
| MoneyControl | $848.95K USD |
| MarketWatch | $848.95K USD |
| marketcap.company | $848.95K USD |
| Reuters | $848.95K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.